QMMM Holdings Limited Ordinary Shares

Fundamentals3.0
Price Action2.0
News Sentiment3.0
AI Rating
2.0

Key Drivers

  • Severe net losses
  • Strong current ratio
  • Massive negative FCF

AI
AI Summary

2.0

QMMM looks like a distressed growth story—severe cash burn, sharp revenue declines, deeply negative margins and a Nasdaq filing notice mean any upside is speculative pending an immediate financing plan, timely Form 20‑F filing, and sequential revenue/margin stabilization.

Turnaround
Governance
Liquidity‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

3.0

Key Financial Insights:

  • Severe net losses
  • Strong current ratio
  • Massive negative FCF

Qorvo shows strong liquidity and very low leverage but severe operating losses and massive negative free cash flow create a high-risk profile unless profitability and cash generation improve.

CashBurn
LowLeverage

Price Behavior

2.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Price unchanged
  • Low liquidity signal
  • No momentum data

QMMM stuck at $119.40 across recent dates implies apparent price stability but likely stale/low‑liquidity quotes that prevent calculating last month trend/momentum and hinder reliable entry/exit — request intraday trades or volume to assess true price.

staleQuotes
priceStable
Support Level: $119.40
Resistance Level: $119.40

Identical quotes across multiple dates indicate stale data or absent trading, preventing trend/volatility analysis

Sentiment & News

3.0

Key News Insights:

  • Form 20-F missing
  • Nasdaq noncompliance
  • No remediation disclosed

QMMM received a Nasdaq notice for failing to timely file its Form 20-F for fiscal year ended 2025-09-30, creating a compliance deficiency without disclosed cause or remediation plan.

Nasdaq

The notice raises short-term regulatory and investor-confidence risk for QMMM, potentially pressuring the stock until the filing or cure is announced